GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Vedanta Ltd

Vedanta Ltd: Board Approves Q2 and H1 FY27 Unaudited Consolidated and Standalone Results

RESULTS ● No Immediate Change MEDIUM RISK
📅 Filed on BSE: 28 Oct 2026, 02:14 PM IST  ·  BSE ID: a84d8ecb-1581-4a12-b9ae-c859f454a085
View Original BSE Filing (PDF)
💡
In Simple Terms
Vedanta's board has approved its latest financial results for the second quarter and first half of the current fiscal year.
🤖 AI Summary
  • Vedanta Ltd's Board approved unaudited consolidated and standalone financial results for Q2 and H1 FY27 on October 28, 2026.
  • Statutory Auditors M/s M S K A & Associates LLP issued a Limited Review Report with an unmodified opinion.
  • The financial results cover the period ended September 30, 2026, as per Regulation 33 and 52 of SEBI Listing Regulations.
  • Related party transactions disclosure for the half-year will be filed along with XBRL for financial results.
  • Auditors' report noted ongoing regulatory investigations mentioned in Notes 8 (a) and (b) of the Statement.
🏢 How This Affects the Company
⚠️
Risk Impact
The auditor's report highlights ongoing investigations by regulatory authorities, including those related to allegations in a short seller report during the previous year, which the company has addressed by providing requested details.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this announcement.
👤
Who Is Affected
All shareholders are affected as the company completes its quarterly financial reporting obligations, providing a basis for future financial disclosures.
🔍
Management Signal
The timely approval of financial results indicates management's adherence to regulatory compliance and reporting schedules.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Review of the detailed unaudited consolidated and standalone financial results for Q2 and H1 FY27.
Assessment of related party transaction disclosures to be filed with XBRL.
Updates on the ongoing regulatory investigations mentioned in the auditor's report.
MEDIUM RISK The auditor's note on ongoing regulatory investigations introduces a monitoring requirement for potential future risks.
💡 Investor Takeaway
Vedanta Ltd's Board approved the unaudited consolidated and standalone financial results for Q2 and H1 FY27 ended September 30, 2026. The statutory auditors issued a limited review report with an unmodified opinion. Full financial figures are expected with the detailed filing.
⚖️ Strengths & Concerns

✅ Positives

  • Statutory Auditors M/s M S K A & Associates LLP provided an unmodified opinion on the unaudited financial results.
  • The company fulfilled its regulatory requirement by submitting the financial results in a timely manner as scheduled.

⚠️ Concerns

  • The auditor's report mentions ongoing investigations by regulatory authorities, citing specific notes 8 (a) and (b) to the financial statement.
  • The Statement includes unreviewed interim financial information from 12 subsidiaries, 2 associates, and 3 joint ventures, as certified by management.
📅 Company Track Record
Vedanta Ltd had previously informed BSE on October 22, 2026, that its Board of Directors would meet on October 28, 2026, to consider and approve the Q2 and H1 FY27 unaudited results.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What financial results did Vedanta Ltd's Board approve on October 28, 2026?
Vedanta Ltd's Board approved the unaudited consolidated and standalone financial results for the Second Quarter and Half Year ended September 30, 2026.
What was the auditors' opinion on Vedanta Ltd's Q2 and H1 FY27 financial results?
The Statutory Auditors, M/s M S K A & Associates LLP, provided a Limited Review Report with an unmodified opinion on the financial results.
Are there any specific matters highlighted in the auditor's report for Vedanta Ltd?
The auditor's report draws attention to Notes 8 (a) and (b) regarding ongoing investigations by regulatory authorities, including those related to short seller allegations from the previous year.
When will the disclosure for related party transactions be filed for Vedanta Ltd?
The disclosure of related party transactions will be filed along with the XBRL for the financial results, as applicable for half-yearly filings.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.